OptiBiotix Health Plc (FRA:OB3)
Germany · Delayed Price · Currency is EUR 0.0845
0.00 (0.00%)
At close: Nov 28, 2025
OptiBiotix Health Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 1.15 | 0.87 | 0.64 | 0.46 | 2.21 | 1.52 | Upgrade | |
Revenue Growth (YoY) | 102.28% | 35.09% | 40.92% | -79.35% | 45.28% | 121.54% | Upgrade |
Cost of Revenue | 0.63 | 0.54 | 0.32 | 0.21 | 1.09 | 0.64 | Upgrade |
Gross Profit | 0.52 | 0.33 | 0.32 | 0.24 | 1.12 | 0.88 | Upgrade |
Selling, General & Admin | 2.87 | 2.3 | 1.79 | 2.51 | 2.2 | 1.74 | Upgrade |
Research & Development | 0.29 | 0.29 | 0.22 | - | - | - | Upgrade |
Operating Expenses | 3.16 | 2.6 | 2.02 | 2.73 | 2.49 | 1.99 | Upgrade |
Operating Income | -2.64 | -2.27 | -1.7 | -2.49 | -1.37 | -1.11 | Upgrade |
Interest Expense | - | - | - | - | -0.05 | -0.04 | Upgrade |
Interest & Investment Income | 0 | 0 | 0 | - | - | 0 | Upgrade |
Earnings From Equity Investments | -0.28 | -0.35 | -0.32 | -0.08 | - | -0.3 | Upgrade |
EBT Excluding Unusual Items | -2.92 | -2.62 | -2.02 | -2.57 | -1.41 | -1.46 | Upgrade |
Gain (Loss) on Sale of Investments | 2.67 | 0.75 | -0.03 | -16.63 | 7.59 | 7.17 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | 21.65 | - | - | Upgrade |
Pretax Income | -0.25 | -1.87 | -2.04 | 2.44 | 6.18 | 5.71 | Upgrade |
Income Tax Expense | -0.06 | -0.06 | -0 | -0.15 | -0.08 | -0.09 | Upgrade |
Earnings From Continuing Operations | -0.19 | -1.81 | -2.04 | 2.59 | 6.26 | 5.8 | Upgrade |
Net Income | -0.19 | -1.81 | -2.04 | 2.59 | 6.26 | 5.8 | Upgrade |
Net Income to Common | -0.19 | -1.81 | -2.04 | 2.59 | 6.26 | 5.8 | Upgrade |
Net Income Growth | - | - | - | -58.68% | 7.91% | - | Upgrade |
Shares Outstanding (Basic) | 102 | 98 | 90 | 88 | 88 | 87 | Upgrade |
Shares Outstanding (Diluted) | 102 | 98 | 90 | 93 | 96 | 96 | Upgrade |
Shares Change (YoY) | 9.20% | 8.55% | -3.24% | -2.43% | -0.03% | 12.09% | Upgrade |
EPS (Basic) | -0.00 | -0.02 | -0.02 | 0.03 | 0.07 | 0.07 | Upgrade |
EPS (Diluted) | -0.00 | -0.02 | -0.02 | 0.03 | 0.07 | 0.06 | Upgrade |
EPS Growth | - | - | - | -57.56% | 7.91% | - | Upgrade |
Free Cash Flow | -1.92 | -1.77 | -1.53 | -1.11 | -1.57 | -0.93 | Upgrade |
Free Cash Flow Per Share | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 | Upgrade |
Gross Margin | 45.44% | 38.05% | 49.69% | 53.39% | 50.75% | 57.76% | Upgrade |
Operating Margin | -229.10% | -260.46% | -263.35% | -544.64% | -61.68% | -72.96% | Upgrade |
Profit Margin | -16.59% | -207.47% | -316.62% | 566.08% | 282.92% | 380.89% | Upgrade |
Free Cash Flow Margin | -166.64% | -203.22% | -237.11% | -242.67% | -70.72% | -60.92% | Upgrade |
EBITDA | -2.43 | -2.06 | -1.49 | -2.27 | -1.08 | -0.86 | Upgrade |
EBITDA Margin | -211.29% | -236.44% | -231.52% | - | -48.67% | -56.69% | Upgrade |
D&A For EBITDA | 0.21 | 0.21 | 0.21 | 0.22 | 0.29 | 0.25 | Upgrade |
EBIT | -2.64 | -2.27 | -1.7 | -2.49 | -1.37 | -1.11 | Upgrade |
EBIT Margin | -229.10% | -260.46% | -263.35% | - | -61.68% | -72.96% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.